Related Experiment Video
Updated: Jun 27, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Steroid-Responsive Parkinsonism and Encephalopathy: A Case Report
Toluwalase Oluwakemi Tofade1,2, G Kyle Harrold1,2,3, Arjun Laud1
1Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
This study highlights a rare case of autoimmune encephalitis (AE) presenting as parkinsonism and encephalopathy. Even with negative antibody tests, AE should be considered in acute parkinsonism.
Area of Science:
- Neurology
- Immunology
Background:
- Autoimmune encephalitis (AE) is a group of immune-mediated disorders affecting the central nervous system.
- While typically presenting with seizures and cognitive decline, AE can manifest with diverse neurological symptoms.
Observation:
- A 71-year-old man developed rapidly progressive parkinsonism and encephalopathy with flu-like symptoms.
- Cerebrospinal fluid (CSF) showed lymphocytic pleocytosis and elevated protein, but neural antibody and infectious workups were negative.
- Brain MRI was initially unremarkable.
Findings:
- The patient's parkinsonism and encephalopathy significantly improved with prednisone treatment and relapsed upon tapering.
- CSF abnormalities also resolved with prednisone, indicating an autoimmune process.
- This case demonstrates subacute parkinsonism as an uncommon presentation of seronegative autoimmune encephalitis.
Implications:
- Physicians should consider autoimmune encephalitis in patients with acute or subacute parkinsonism, even with negative antibody tests.
- This case underscores the expanding spectrum of autoimmune neurology and the importance of considering seronegative AE.
- Early recognition and treatment with immunotherapy can lead to significant clinical improvement in these rare AE presentations.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Lysosomal Hydrolases
REM Sleep Behavior Disorder
RBD is significantly associated with...